GGrantIndex
← Leaderboards

Christina Louise Lancioni

Case Western Reserve University

$5,185,309
Attributed
$7,537,172
Total exposure
4
Grants
4
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.4M · FY200925
$2M$1.5M$1M$500K$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$7,537,172 · 4

By mechanism

R01$6,592,377 · 2
K08$636,795 · 1
R03$308,000 · 1

Top collaborators

Most similar at Case Western Reserve University

Same institution · by research overlap

Others in their field

Top investigators on “Cytokine

Research focus

CytokineCd4 Positive T LymphocytesResponseMorbidity - Disease RateHiv InfectionsImmuneMortalityImmune ResponseImmune SystemProductionPathway InteractionsT-Cell ActivationMediatingSamplingEpidemiologyExhibitsPhenotypeFlow CytometryRecording Of Previous EventsMycobacterium TuberculosisDesignInfectionMicrobialCell Physiology

Grant awards (18)

Defining adaptive immune responses to Mtb-infection and TB disease among young children with and without HIV-exposure$724,871
R01 · FY2025 · AI · contact PI
Defining adaptive immune responses to Mtb-infection and TB disease among young children with and without HIV-exposure$713,830
R01 · FY2024 · AI · contact PI
Defining adaptive immune responses to Mtb-infection and TB disease among young children with and without HIV-exposure$701,086
R01 · FY2023 · AI · contact PI
Defining adaptive immune responses to Mtb-infection and TB disease among young children with and without HIV-exposure$674,625
R01 · FY2022 · AI · contact PI
The impact of naltrexone treatment on opioid-induced immune and viral dysregulation during HIV-infection$613,376
R01 · FY2022 · DA · contact PI
Defining adaptive immune responses to Mtb-infection and TB disease among young children with and without HIV-exposure$713,382
R01 · FY2021 · AI · contact PI
The impact of naltrexone treatment on opioid-induced immune and viral dysregulation during HIV-infection$655,970
R01 · FY2021 · DA · contact PI
The impact of naltrexone treatment on opioid-induced immune and viral dysregulation during HIV-infection$735,253
R01 · FY2020 · DA · contact PI
The impact of naltrexone treatment on opioid-induced immune and viral dysregulation during HIV-infection$644,219
R01 · FY2019 · DA · contact PI
The impact of naltrexone treatment on opioid-induced immune and viral dysregulation during HIV-infection$415,765
R01 · FY2018 · DA · contact PI
Immune dysregulation in HIV-infected adults with substance abuse and the impact of addiction therapy$154,000
R03 · FY2017 · DA · contact PI
Immune dysregulation in HIV-infected adults with substance abuse and the impact of addiction therapy$154,000
R03 · FY2016 · DA · contact PI
MTB directly regulates human CD4+ T cell activation$127,845
K08 · FY2013 · AI · contact PI
MTB directly regulates human CD4+ T cell activation$127,845
K08 · FY2012 · AI · contact PI
MTB directly regulates human CD4+ T cell activation$127,440
K08 · FY2011 · AI · contact PI
MTB directly regulates human CD4+ T cell activation$118,976
K08 · FY2010 · AI · contact PI
MTB directly regulates human CD4+ T cell activation$8,059
K08 · FY2010 · AI · contact PI
MTB directly regulates human CD4+ T cell activation$126,630
K08 · FY2009 · AI · contact PI